中文 | English
Return
Total: 545 , 1/55
Show Home Prev Next End page: GO
Author:(Xue-zhong ZHANG)

1.A case report and literature review on anakinra in the treatment of refractory adult onset Still’s disease

Yumin YAN ; Jie LIU ; Xia ZHANG ; Xue ZHONG

China Pharmacy 2025;36(19):2442-2447

2. Mechanism of ellagic acid improving cognitive dysfunction in APP/PS double transgenic mice based on PI3K/AKT/GSK-3β signaling pathway

Li-Li ZHONG ; Xin LU ; Ying YU ; Qin-Yan ZHAO ; Jing ZHANG ; Tong-Hui LIU ; Xue-Yan NI ; Li-Li ZHONG ; Yan-Ling CHE ; Dan WU ; Hong LIU

Chinese Pharmacological Bulletin 2024;40(1):90-98

3.Study on the antitussive and expectorant activities and mechanism of platycodin D based on metabolomics method

Xin-yu ZHANG ; Yuan-han ZHONG ; Yan FENG ; Xue-mei ZHANG ; Shou-wen ZHANG ; Jin-xiang ZENG

Acta Pharmaceutica Sinica 2024;59(3):724-734

4.Study on the Effect of Liuwei Dihuang Pills on Regulating the Antigen Cross-Presenting Ability of Dendritic Cells by Interfering with Gap Junctional Communication Function

Yue SONG ; Man-Si XU ; Xue-Ying ZHONG ; Wen-Jing ZHANG ; Xiao-Yi CHEN ; Biao-Yan DU ; Jian-Yong XIAO ; Kun WANG

Journal of Guangzhou University of Traditional Chinese Medicine 2024;41(1):169-177

5.Expert opinions on operation rules of Morita therapy outpatient service

Jiangbo LI ; Zucheng WANG ; Yuhua CUI ; Yingzhi LU ; Weijie QU ; Haiyin ZHANG ; Fuqiang MAO ; Fengqing QIE ; Wanghong SHI ; Qinfeng ZHANG ; Lingyi PAN ; Ling ZHANG ; Jianzhong LI ; Guangcheng CUI ; Tongxian CHEN ; Xiuqing MA ; Wei RONG ; Jianjun ZHANG ; Qingfang ZHONG ; Yanchi ZHANG ; Boquan ZHANG ; Xinrui WANG ; Wenyou MA ; Qingtao REN ; Yongfa JING ; Huanzhong LIU ; Zhenjian YU ; Laitian ZHAO ; Tianming HAN ; Xue HAN

Chinese Mental Health Journal 2024;38(1):68-72

6.A novel chalcone derivative C13 inhibits the growth of human gastric cancer cells through suppressing ErbB4/PI3K/AKT signaling pathway

Peng TAN ; Yun-feng ZHANG ; Long-yan WANG ; Hui-ming HUANG ; Fei WANG ; Xue-jiao WEI ; Zhu-guo WANG ; Jun LI ; Zhong-dong HU

Acta Pharmaceutica Sinica 2024;59(4):957-964

7.ox-LDL Promotes Bidirectional Regulation of Neuronal Apoptosis Through The PCSK9/LRP1 Signaling Pathway

Nai-Qi HE ; Xue-Shan ZHAO ; Qian XU ; Hua-Yu ZHANG ; Zhong REN ; Zhi-Han TANG ; Qiong XIANG ; Lu-Shan LIU

Progress in Biochemistry and Biophysics 2024;51(4):944-958

8.Application value of papaverine combined with staged rehabilitation in patients after free flap transplantation for hand trauma

Yuehong ZHANG ; Chunyan JIANG ; Xueyan ZHAO ; Su ZHONG ; Chunmei XUE ; Xuanchen CHEN

China Pharmacist 2024;27(8):1327-1335

9.The prevalence and related risk factors of hyperuricemia in Bozidum Kinghiz township of Xinjiang Aksu region

Yan ZHONG ; Nasha GU ; Zhengfang LI ; Xue WU ; Mansuer MIKELAYI· ; Yamei SHI ; Cainan LUO ; Xiaomei CHEN ; Qianqian WANG ; Chaohong YUE ; Yun FENG ; Xinyan MENG ; Guoli ZHANG ; Juan DENG ; Jing LI ; Lijun WU

Chinese Journal of Rheumatology 2024;28(5):312-320

10.Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Clinical Significance

Meng WANG ; Ping-Ping ZHANG ; Qing ZHU ; Zhong-Li HU ; Xue BAI ; Yan-Ping WU ; Jia-Jia LI

Journal of Experimental Hematology 2024;32(1):112-119

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 545 , 1/55 Show Home Prev Next End page: GO